$67.72
In chiusura: Oct 6 EDT
$67.10
-0.62-0.91%
Pre-mercato: 5:40 PM EDT
Il short interest su Tarsus Pharmaceuticals Inc (NASDAQ:TARS) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 6.93M a 7.63M. Questo rappresenta il 18.7% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Tarsus Pharmaceuticals Corp (XNAS:TARS) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 832.79K azioni scambiate al giorno, ci vorrebbero 9.17 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|
TARS | Tarsus Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 18.70% | 40,825,262 | 7,634,147 | 832,786 | 9.17 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 16.96% | 40,825,262 | 6,925,599 | 533,007 | 12.99 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 17.98% | 40,825,262 | 7,339,962 | 803,354 | 9.14 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 19.93% | 40,825,262 | 8,136,900 | 561,118 | 14.5 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 20.21% | 40,618,193 | 8,208,464 | 563,522 | 14.57 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 21.81% | 40,618,193 | 8,856,844 | 644,925 | 13.73 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 19.97% | 40,618,193 | 8,111,634 | 551,901 | 14.7 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 19.88% | 40,618,193 | 8,073,126 | 484,050 | 16.68 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 19.15% | 40,618,193 | 7,779,546 | 873,354 | 8.91 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 20.46% | 40,618,193 | 8,308,925 | 655,639 | 12.67 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 21.03% | 39,843,167 | 8,378,489 | 693,077 | 12.09 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 19.20% | 39,843,167 | 7,651,107 | 729,772 | 10.48 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 18.58% | 39,843,167 | 7,403,040 | 593,663 | 12.47 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 19.83% | 37,034,179 | 7,342,164 | 791,300 | 9.28 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 19.13% | 37,034,179 | 7,082,922 | 454,438 | 15.59 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 19.90% | 36,883,930 | 7,339,031 | 460,777 | 15.93 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 19.03% | 36,883,930 | 7,020,304 | 994,905 | 7.06 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 19.87% | 36,883,930 | 7,328,028 | 520,937 | 14.07 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 20.45% | 36,883,930 | 7,543,047 | 506,601 | 14.89 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 19.47% | 36,883,930 | 7,180,505 | 492,680 | 14.57 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 19.36% | 36,883,930 | 7,140,778 | 1,069,725 | 6.68 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 22.23% | 36,698,738 | 8,157,528 | 931,859 | 8.75 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 26.37% | 36,698,738 | 9,677,608 | 493,812 | 19.6 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 27.12% | 36,698,738 | 9,951,316 | 566,107 | 17.58 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 25.87% | 36,698,738 | 9,494,579 | 802,472 | 11.83 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 26.69% | 36,698,738 | 9,794,162 | 546,104 | 17.93 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 26.59% | 36,698,738 | 9,758,485 | 731,479 | 13.34 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 24.16% | 36,438,694 | 8,805,240 | 615,715 | 14.3 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 23.22% | 36,438,694 | 8,459,817 | 972,451 | 8.7 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 21.85% | 36,438,694 | 7,963,194 | 590,992 | 13.47 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 20.52% | 36,438,694 | 7,476,397 | 432,557 | 17.28 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 20.51% | 36,438,694 | 7,472,293 | 742,567 | 10.06 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 21.02% | 36,438,694 | 7,659,886 | 393,252 | 19.48 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 21.68% | 36,433,666 | 7,899,607 | 631,298 | 12.51 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 21.93% | 35,800,684 | 7,850,374 | 487,094 | 16.12 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 20.10% | 35,800,684 | 7,195,486 | 834,768 | 8.62 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 16.85% | 35,800,684 | 6,031,793 | 1,147,280 | 5.26 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 17.29% | 31,405,160 | 5,430,409 | 786,907 | 6.9 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 15.97% | 31,405,160 | 5,015,635 | 631,700 | 7.94 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 15.93% | 31,405,160 | 5,002,701 | 730,745 | 6.85 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 15.63% | 31,405,160 | 4,909,365 | 642,692 | 7.64 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 14.18% | 31,405,160 | 4,454,107 | 623,706 | 7.14 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 14.20% | 31,405,160 | 4,459,315 | 726,280 | 6.14 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 13.57% | 30,917,065 | 4,196,720 | 420,140 | 9.99 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 10/13/2023 | 10/24/2023 | 12.94% | 30,917,065 | 3,999,881 | 559,909 | 7.14 | |
TARS | Tarsus Pharmaceuticals, Inc. C | 09/29/2023 | 10/10/2023 | 16.05% | 30,917,065 | 4,962,883 | 357,289 | 13.89 |
In cerca di azioni più vendute allo scoperto?